ALDURAZYME (Genzyme Corporation)


Welcome to the PulseAid listing for the ALDURAZYME drug offered from Genzyme Corporation. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genzyme Corporation
NON-PROPRIETARY NAME: laronidase
SUBSTANCE NAME: LARONIDASE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2003-04-30
END MARKETING DATE: 0000-00-00


ALDURAZYME HUMAN PRESCRIPTION DRUG Details:

Item DescriptionALDURAZYME from Genzyme Corporation
LABELER NAME: Genzyme Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 2.9(mg/5mL)
START MARKETING DATE: 2003-04-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58468-0070_fd3076d5-6e80-4457-9b59-8968630a3ad0
PRODUCT NDC: 58468-0070
APPLICATION NUMBER: BLA125058

Other LARONIDASE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genzyme CorporationALDURAZYME